Trials / Recruiting
RecruitingNCT07055919
Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER).
A Prospective, Multicenter, Stratified Randomized Controlled, Non-Inferiority Clinical Trial to Evaluate the Safety and Efficacy of the Structural Heart Surgery Assist System for Transcatheter Mitral Valve Edge-to-Edge Repair (TEER).
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 112 (estimated)
- Sponsor
- Xiamen Cardiovascular Hospital, Xiamen University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This trial aims to evaluate the safety and efficacy of the Structural Heart Surgery Assist System in assisting TEER for patients with moderate-to-severe or greater degenerative or functional mitral regurgitation (MR ≥3+). A prospective, multicenter, stratified randomized controlled design with non-inferiority comparison will be used. The experimental group will utilize the Structural Heart Surgery Assist System, while the control group will undergo manual TEER (e.g., MitraClip G4).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Structural Heart Surgery Assist System | Following femoral venous access and transseptal puncture, the steerable guide catheter and transcatheter mitral valve clip system are inserted and mounted onto the Structural Heart Surgery Assist System. The surgeon manipulates the joystick and controls on the operator console, guided by real-time animations on the human-machine interface that confirm the direction and range of device motion. Under fluoroscopic (DSA) and echocardiographic guidance, the system assists in performing edge-to-edge mitral valve repair. The procedure achieves regurgitation reduction by either creating a double-orifice configuration (A2/P2 segments) or approximating the opposing leaflets at the A1/P1 or A3/P3 regions. |
| DEVICE | Manual MitraClip G4 | Manual MitraClip G4 |
Timeline
- Start date
- 2025-03-22
- Primary completion
- 2026-03-22
- Completion
- 2026-04-22
- First posted
- 2025-07-09
- Last updated
- 2025-07-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07055919. Inclusion in this directory is not an endorsement.